In a resounding triumph for the European MedTech industry, the Austrian powerhouse, Biome Diagnostics, has emerged as a beacon of excellence and innovation. We proudly congratulate Biome Diagnostics for its remarkable achievements and groundbreaking contributions to the field of medical microbiome diagnostics. The company’s recent rewards and recognition not only underscore its commitment to revolutionizing healthcare. They also highlight the dynamic and thriving landscape of European startups on the global stage.

A Trailblazer in Medical Microbiome Diagnostics 

Biome Diagnostics, headquartered in Vienna, has emerged as a pioneer in the field of medical microbiome diagnostics. Their relentless pursuit of excellence has led to the development of groundbreaking oncology and preventive solutions. These are significant contributions to advancements in personalized medicine. Therefore, this commitment to innovation and transformative healthcare solutions has now been recognized and celebrated on multiple fronts. 

EIT Health Catapult Finals Triumph 

At the prestigious EIT Health Catapult Finals, hosted during the Bits & Pretzels HealthTech conference in Munich, Biome Diagnostics achieved a special success. The company secured an impressive 2nd place in the fiercely competitive MedTech category. This remarkable accomplishment not only came with a substantial cash prize but also earned Biome Diagnostics a series of industry accolades. 

Particularly noteworthy was the highly coveted Alex Casta Audience Award. This recognition by the discerning audience underscores the impact of Biome Diagnostics’ innovations in the field of medical microbiome diagnostics. In a testament to their global reach, the company’s logo will now grace the NASDAQ Tower in the iconic Times Square. Additionally, it ensures that its visionary contributions are showcased to millions of people worldwide. 

Born Global Champion 2023: A Triumph on Home Soil 

Biome Diagnostics’ international success has also resonated on a national level, garnering acclaim and recognition within Austria. The Austrian Chamber of Commerce (WKÖ) Export Day honored the company with the esteemed “Born Global Champion 2023″ Award. Not only serves this accolade as a resounding validation of the company’s rapid growth and innovative offerings. It also showcases its remarkable success in international markets from its inception. 

A Visionary Path Forward 

The triumphs at the EIT Health Catapult Finals and the Born Global Champion 2023 Award underscore Biome Diagnostics’ dedication to advancing personalized medicine through cutting-edge microbiome diagnostics. Dr. Nikolaus Gasche, Co-Founder and Managing Director of Biome Diagnostics, expressed his gratitude for the recent successes. Furthermore, he emphasized the importance of reaching millions with the company’s pioneering vision. 

Barbara Sladek, PhD, MBA, Co-Founder and Managing Director of Biome Diagnostics, echoed these sentiments. She was especially highlighting the award as a testament to the company’s commitment to positively impacting global healthcare through innovative microbiome solutions. 

We proudly celebrate the resounding success of Biome Diagnostics. It is a shining example of the remarkable achievements and groundbreaking innovations flourishing within the European MedTech landscape. Biome Diagnostics’ triumphs at the EIT Health Catapult Finals and the Born Global Champion 2023 Award. This undoubtedly underscores its unwavering dedication to revolutionizing healthcare through transformative microbiome diagnostics. Biome Diagnostics’ visionary contributions will continue to inspire and catalyze advancements in personalized medicine on a global scale.